Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

Daniel Rubin, PhD

FDA

Disclosure(s): No financial relationships to disclose

Poster(s):

(P-106) Exploration of a Desirability of Outcome Ranking (DOOR) Endpoint for Invasive Aspergillosis Using Two Registrational Trials

Monday, October 20, 2025
12:15 PM - 1:30 PM US ET